Post-earnings recap
Reported
Mon, Oct 27, 2025
EPS actual
$0.12
EPS est.
$0.80
EPS surprise
-84.98%
1-day move
-3.32%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
BioMarin's disappointing EPS results indicate significant challenges in the current quarter, leading to a stock decline of 3.32%. The lack of revenue information and guidance updates adds uncertainty for investors. Management's defensive tone suggests they are aware of the issues but are focused on long-term solutions.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.12 | N/A | -84.98% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a cautious outlook, recognizing the difficulties in meeting expectations. They are committed to addressing these issues moving forward.
Management acknowledged the challenges faced this quarter.
They emphasized a focus on long-term strategies despite current setbacks.